查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878846

奈米醫學市場－全球產業規模、佔有率、趨勢、機會和預測，按奈米分子類型、奈米顆粒類型、應用、疾病適應症、地區和競爭格局分類，2020-2030年預測

Nanomedicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Nanomolecule Type, By Nanoparticles Type, By Application By Disease Indication, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球奈米醫學市場規模為1,741億美元，預計2030年將以9.10%的複合年成長率成長至2,935.9億美元。奈米醫學是指將奈米技術應用於醫療保健領域，利用尺寸通常在1至100奈米之間的材料和設備進行疾病的診斷、治療和預防。這種方法利用奈米結構的獨特特性來提高藥物的溶解度、穩定性、標靶遞送和生物利用度。

市場概覽
預測期 2026-2030
2024年市場規模 1741億美元
2030年市場規模 2935.9億美元
2025-2030年複合年成長率 9.1%
成長最快的細分市場 奈米顆粒
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球奈米醫學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依奈米分子類型（奈米顆粒、奈米殼、奈米裝置、奈米管）
    • 依奈米顆粒類型（聚合物基、脂質基、奈米晶體、無機、其他）
    • 依應用領域（藥物傳遞、疫苗、診斷影像、再生醫學、其他）
    • 依疾病適應症分類（腫瘤疾病、傳染病、骨科疾病、心血管疾病、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美奈米醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲奈米醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太奈米醫藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲奈米醫學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲奈米醫藥市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球奈米醫學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Pfizer Inc.
  • Johnson & Johnson Innovative Medicine
  • Sanofi SA
  • Amgen Inc.
  • Moderna, Inc.
  • Novo Nordisk A/S
  • Genentech, Inc.
  • Celgene Corporation
  • Vifor Pharma Group
  • Teva Pharmaceutical Industries Ltd.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 10570

The Global Nanomedicine Market, valued at USD 174.10 Billion in 2024, is projected to experience a CAGR of 9.10% to reach USD 293.59 Billion by 2030. Nanomedicine represents the application of nanotechnology in healthcare, utilizing materials and devices typically ranging from 1 to 100 nanometers for the diagnosis, treatment, and prevention of diseases. This approach leverages the unique properties of nanoscale structures to enhance drug solubility, stability, targeted delivery, and bioavailability.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 174.10 Billion
Market Size 2030USD 293.59 Billion
CAGR 2025-20309.1%
Fastest Growing SegmentNanoparticles
Largest MarketNorth America

Key Market Drivers

The global nanomedicine market experiences significant impetus from two primary factors: ongoing advancements in nanotechnology innovation and the increasing prevalence of chronic diseases. Technological progress consistently yields novel tools and materials, enabling sophisticated diagnostic and therapeutic applications within healthcare. For instance, according to the National Institutes of Health, in July 2023, the Notice of Funding Opportunity for "Innovative Research in Cancer Nanotechnology (IRCN) R01 Grant" was published, with application deadlines including November 2023 and May 2024, demonstrating sustained investment in fundamental research in this specialized area. Concurrently, the rising global burden of chronic diseases intensifies the demand for more effective medical interventions.

Key Market Challenges

A significant challenge impeding the expansion of the Global Nanomedicine Market is the substantial cost associated with the development and complex manufacturing processes of these specialized products. The intricate nature of nanotechnology-based interventions necessitates considerable upfront investment in research, highly specialized equipment, advanced infrastructure, and a workforce with unique expertise. These requirements often lead to protracted development timelines and increased operational expenditures throughout the product lifecycle, from initial synthesis to large-scale production.

Key Market Trends

The increasing shift towards personalized nanomedicine stands as a significant factor shaping the global nanomedicine market. This trend emphasizes tailoring medical treatments to individual patient characteristics, leveraging nanotechnology's ability to deliver drugs precisely and enhance diagnostic accuracy. Personalized nanomedicine offers the potential for improved therapeutic efficacy and reduced adverse effects by targeting specific cells or tissues. According to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U. S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. This demonstrates a growing regulatory recognition and market adoption of personalized approaches, which nanomedicine profoundly supports.

Key Market Players

  • Pfizer Inc.
  • Johnson & Johnson Innovative Medicine
  • Sanofi S.A.
  • Amgen Inc.
  • Moderna, Inc.
  • Novo Nordisk A/S
  • Genentech, Inc.
  • Celgene Corporation
  • Vifor Pharma Group
  • Teva Pharmaceutical Industries Ltd.

Report Scope:

In this report, the Global Nanomedicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nanomedicine Market, By Nanomolecule Type:

  • Nanoparticles
  • Nanoshells
  • Nanodevices
  • Nanotubes

Nanomedicine Market, By Nanoparticles Type:

  • Polymer-based
  • Lipid-based
  • Nanocrystals
  • Inorganic
  • Others

Nanomedicine Market, By Application:

  • Drug Delivery
  • Vaccines
  • Diagnostic Imaging
  • Regenerative Medicine
  • Others

Nanomedicine Market, By Disease Indication:

  • Oncological Diseases
  • Infectious Diseases
  • Orthopedic Disorders
  • Cardiovascular Diseases
  • Others

Nanomedicine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Nanomedicine Market.

Available Customizations:

Global Nanomedicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nanomedicine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Nanomolecule Type (Nanoparticles, Nanoshells, Nanodevices, Nanotubes)
    • 5.2.2. By Nanoparticles Type (Polymer-based, Lipid-based, Nanocrystals, Inorganic, Others)
    • 5.2.3. By Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Others)
    • 5.2.4. By Disease Indication (Oncological Diseases, Infectious Diseases, Orthopedic Disorders, Cardiovascular Diseases, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Nanomedicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Nanomolecule Type
    • 6.2.2. By Nanoparticles Type
    • 6.2.3. By Application
    • 6.2.4. By Disease Indication
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nanomedicine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Nanomolecule Type
        • 6.3.1.2.2. By Nanoparticles Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Disease Indication
    • 6.3.2. Canada Nanomedicine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Nanomolecule Type
        • 6.3.2.2.2. By Nanoparticles Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Disease Indication
    • 6.3.3. Mexico Nanomedicine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Nanomolecule Type
        • 6.3.3.2.2. By Nanoparticles Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Disease Indication

7. Europe Nanomedicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Nanomolecule Type
    • 7.2.2. By Nanoparticles Type
    • 7.2.3. By Application
    • 7.2.4. By Disease Indication
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nanomedicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Nanomolecule Type
        • 7.3.1.2.2. By Nanoparticles Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Disease Indication
    • 7.3.2. France Nanomedicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Nanomolecule Type
        • 7.3.2.2.2. By Nanoparticles Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Disease Indication
    • 7.3.3. United Kingdom Nanomedicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Nanomolecule Type
        • 7.3.3.2.2. By Nanoparticles Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Disease Indication
    • 7.3.4. Italy Nanomedicine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Nanomolecule Type
        • 7.3.4.2.2. By Nanoparticles Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Disease Indication
    • 7.3.5. Spain Nanomedicine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Nanomolecule Type
        • 7.3.5.2.2. By Nanoparticles Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Disease Indication

8. Asia Pacific Nanomedicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Nanomolecule Type
    • 8.2.2. By Nanoparticles Type
    • 8.2.3. By Application
    • 8.2.4. By Disease Indication
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Nanomedicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Nanomolecule Type
        • 8.3.1.2.2. By Nanoparticles Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Disease Indication
    • 8.3.2. India Nanomedicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Nanomolecule Type
        • 8.3.2.2.2. By Nanoparticles Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Disease Indication
    • 8.3.3. Japan Nanomedicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Nanomolecule Type
        • 8.3.3.2.2. By Nanoparticles Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Disease Indication
    • 8.3.4. South Korea Nanomedicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Nanomolecule Type
        • 8.3.4.2.2. By Nanoparticles Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Disease Indication
    • 8.3.5. Australia Nanomedicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Nanomolecule Type
        • 8.3.5.2.2. By Nanoparticles Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Disease Indication

9. Middle East & Africa Nanomedicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Nanomolecule Type
    • 9.2.2. By Nanoparticles Type
    • 9.2.3. By Application
    • 9.2.4. By Disease Indication
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Nanomedicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Nanomolecule Type
        • 9.3.1.2.2. By Nanoparticles Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Disease Indication
    • 9.3.2. UAE Nanomedicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Nanomolecule Type
        • 9.3.2.2.2. By Nanoparticles Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Disease Indication
    • 9.3.3. South Africa Nanomedicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Nanomolecule Type
        • 9.3.3.2.2. By Nanoparticles Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Disease Indication

10. South America Nanomedicine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Nanomolecule Type
    • 10.2.2. By Nanoparticles Type
    • 10.2.3. By Application
    • 10.2.4. By Disease Indication
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nanomedicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Nanomolecule Type
        • 10.3.1.2.2. By Nanoparticles Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Disease Indication
    • 10.3.2. Colombia Nanomedicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Nanomolecule Type
        • 10.3.2.2.2. By Nanoparticles Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Disease Indication
    • 10.3.3. Argentina Nanomedicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Nanomolecule Type
        • 10.3.3.2.2. By Nanoparticles Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Disease Indication

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Nanomedicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Pfizer Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Johnson & Johnson Innovative Medicine
  • 15.3. Sanofi S.A.
  • 15.4. Amgen Inc.
  • 15.5. Moderna, Inc.
  • 15.6. Novo Nordisk A/S
  • 15.7. Genentech, Inc.
  • 15.8. Celgene Corporation
  • 15.9. Vifor Pharma Group
  • 15.10. Teva Pharmaceutical Industries Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer